脓毒症诱导的心肌病:机制、患病率、评估、预后与管理
本文综述脓毒症诱导的心肌病(SICM)的机制、患病率、评估、预后与管理。SICM传统上定义为可逆性左室收缩功能障碍,但新证据显示其包括左室舒张功能障碍、高动力左室收缩状态和右室损伤,可单独或合并出现。病理生理涉及炎症细胞因子、线粒体功能障碍、冠状动脉微循环改变和负荷条件动态变化。超声心动图因广泛可用、无创且能全面评估血流动力学,已成为脓毒症心脏功能评估的主要手段;新发左室收缩功能障碍约见于5%至32%的脓毒症患者,左室舒张功能障碍和右室损伤分别报告为20%至57%和18%至79%,所有心脏表型均与死亡率显著增加相关。目前尚无靶向治疗显示生存获益,但识别SICM表型至关重要,基于表型的个体化方法可能优化管理。
要点
- SICM包括左室收缩功能障碍、左室舒张功能障碍、高动力左室状态和右室损伤等多种表型,可单独或合并出现。
- 新发左室收缩功能障碍约见于5%至32%的脓毒症患者,左室舒张功能障碍为20%至57%,右室损伤为18%至79%。
- 所有SICM心脏表型均与死亡率显著增加相关。
- 超声心动图是评估脓毒症心脏功能的主要手段,纵向左室功能和心室-动脉耦联等新指标可补充左室射血分数等常规参数。
- 目前尚无靶向治疗显示生存获益,管理需基于表型的个体化方法而非标准化复苏策略。
适用人群与场景
- 脓毒症和脓毒性休克患者。
处置流程与药物剂量
- 管理需要基于表型的个体化方法,而非标准化复苏策略。
研究设计与关键结果
- 综述指出,SICM的病理生理涉及炎症细胞因子、线粒体功能障碍、冠状动脉微循环改变和负荷条件动态变化。
- 超声心动图因广泛可用、无创且能全面评估血流动力学,已成为脓毒症心脏功能评估的主要手段。
- 纵向左室功能和心室-动脉耦联等新指标可补充左室射血分数或其他常规参数。
- 诊断心肌功能障碍的敏感性和特异性存在固有差异,加之定义不一致,导致报告的患病率差异很大。
- 新发左室收缩功能障碍约见于5%至32%的脓毒症患者,左室舒张功能障碍和右室损伤分别报告为20%至57%和18%至79%。
- 所有心脏表型均与死亡率显著增加相关。
- 目前尚无靶向治疗显示生存获益。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,识别SICM表型至关重要,基于表型的个体化方法可能优化管理。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
TOPIC IMPORTANCE: Sepsis-induced cardiomyopathy (SICM) is a heterogeneous cardiovascular dysfunction associated with sepsis and septic shock. Although traditionally defined by reversible left ventricular (LV) systolic dysfunction, recent evidence has revealed a broader spectrum, including LV diastolic dysfunction, hyperdynamic LV systolic states, and right ventricular (RV) injury, occurring independently or in combination. Despite their prognostic significance, these phenotypes remain underrecognized and understudied.
REVIEW FINDINGS: The pathophysiology of SICM involves inflammatory cytokines, mitochondrial dysfunction, altered coronary microcirculation, and dynamic changes in loading conditions. Echocardiography, because it is widely available, noninvasive, and capable of comprehensive hemodynamic evaluation, has become the primary modality for assessing cardiac function in sepsis. Emerging measures, including longitudinal LV function and ventriculo-arterial coupling, supplement the LV ejection fraction or other conventional parameters. The inherent differences in sensitivity and specificity in diagnosing myocardial dysfunction along with inconsistent definitions have led to wide variability in reported prevalence. New-onset LV systolic dysfunction occurs in approximately 5% to 32% of patients with sepsis, whereas LV diastolic dysfunction and RV injury are reported in 20% to 57% and 18% to 79%, respectively. All these cardiac phenotypes are associated with significantly increased mortality. Management requires phenotype-guided, individualized approaches rather than standardized resuscitation strategies.
SUMMARY: SICM comprises a spectrum of cardiac abnormalities, including LV systolic dysfunction, hyperdynamic LV function, diastolic dysfunction, and RV injury. Although no targeted therapies have shown survival benefit, recognition of SICM phenotypes is crucial. A tailored, phenotype-guided approach may optimize management.
参考来源
- Sato R, Sanfilippo F, Lanspa M, et al. Sepsis-Induced Cardiomyopathy: Mechanism, Prevalence, Assessment, Prognosis, and Management. Chest. 2025. PMID: 40912296. doi:10.1016/j.chest.2025.08.013
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。